• Profile
Close

Therapeutic role of intravenous glycerol for Meniere’s disease. Preliminary results

American Journal of Otolaryngology - Head and Neck Medicine and Surgery May 09, 2020

Scarpa A, Cassandro C, De Luca P, et al. - In the present study, the researchers sought to assess the effectiveness on symptom control of intravenous glycerol in a sample of individuals with definite unilateral Meniere's disease (MD) not responsive to dietary restrictions. Participants in the study were 40 patients with unilateral intractable MD. Following audio-vestibular examination, patients were treated with intravenous 10% glycerol with 0.9% sodium chloride, 0.5 g/kg ml once daily for 2 consecutive days every fifteen days for six months. Through the Tinnitus Handicap Inventory and the Functionality Level Scale questionnaires, tinnitus and quality of life were assessed. In the study, two consecutive days of intravenous infusion of glycerol every fifteen days for six months, based on the patient's weight, improved vertigo attacks and reduced the discomfort caused by tinnitus increasing quality of life in patients with unilateral MD unresponsive to dietary restrictions. No deterioration of the hearing was found in all treated patients.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay